Stephanie Lovell - May 27, 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
/s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
May 27, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 05:20 PM
Next filing
Jun 28, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +2.25K $0.00 2.25K May 27, 2021 Common Stock 2.25K $26.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to one-third of the shares subject to the option on March 22, 2022 and in equal monthly installments as to the remainder of the shares for two years thereafter.